Two Peptides Grouped Under "Mitochondrial," For Different Reasons
MOTS-C and SS-31 (elamipretide) both appear on lists of mitochondria-related research peptides, and it is common to see them mentioned side by side. That grouping is useful shorthand, but it can obscure how different these two molecules actually are. One is a naturally encoded peptide that participates in cell signaling. The other is a synthetic peptide engineered to associate with a specific mitochondrial membrane component. Researchers choosing between them, or deciding whether a study design calls for one, the other, or both, benefit from understanding that distinction before looking at receptor pathways or study models.
This article compares the origin, structure, and general research focus of MOTS-C and SS-31, and outlines practical considerations for sourcing and documentation. It does not describe outcomes, benefits, or applications; it describes what each compound is and what categories of research literature have examined.
MOTS-C: A Mitochondrial-Genome-Encoded Peptide
Origin and Structure
MOTS-C is a short peptide, sixteen amino acids in its studied form, that is encoded within the mitochondrial genome rather than the nuclear genome. It belongs to a small class of mitochondrial-derived peptides (MDPs) that also includes humanin and the SHLP series. Because its coding sequence sits inside the mitochondrial 12S rRNA region, MOTS-C is often discussed in the literature as an example of the mitochondrial genome contributing directly to intracellular signaling, rather than only to oxidative phosphorylation machinery.
Research Focus
Cell biology and metabolic research involving MOTS-C has examined its behavior as a signaling peptide, including work on translocation between cytoplasmic and nuclear compartments under conditions of metabolic stress in cell culture models. Related research threads look at MOTS-C in the context of AMPK-linked signaling pathways, which places it within a broader research literature on cellular energy-sensing mechanisms. Study models range from in vitro cell culture to rodent models, with researchers using MOTS-C to probe how mitochondria-encoded peptides participate in signaling pathways typically associated with the nucleus.
SS-31 (Elamipretide): A Synthetic Membrane-Targeted Peptide
Origin and Structure
SS-31 is a synthetic aromatic-cationic tetrapeptide, not a product of any genome. Its design, alternating aromatic and basic residues, gives it a structural property that mitochondrial-genome-encoded peptides like MOTS-C do not share: it concentrates selectively at the inner mitochondrial membrane, where it is studied for its association with cardiolipin, a phospholipid concentrated in that membrane and linked to electron transport chain organization.
Research Focus
Published research on SS-31 centers on mitochondrial membrane biology and bioenergetics, including cardiolipin interaction, electron transport chain complex organization, and reactive oxygen species handling within isolated mitochondria and tissue-based models. Because its mechanism of interest is structural and membrane-localized rather than transcriptional or nuclear, SS-31 research tends to use different endpoints than MOTS-C research, typically respirometry, membrane potential measurement, and biochemical assays of mitochondrial fractions rather than nuclear signaling readouts.
Comparing the Two Directly
- Genetic origin. MOTS-C is encoded in the mitochondrial genome; SS-31 is a fully synthetic peptide with no natural coding sequence.
- Primary site of interest. MOTS-C research follows the peptide into the cytoplasm and nucleus under certain conditions; SS-31 research keeps its focus at the inner mitochondrial membrane.
- Mechanistic category. MOTS-C is studied as a signaling molecule connected to energy-sensing pathways such as AMPK; SS-31 is studied as a membrane-stabilizing and cardiolipin-associated compound.
- Typical study readouts. MOTS-C studies often report on gene expression or signaling pathway activity; SS-31 studies more often report on respirometric or membrane-biochemical measurements.
- Class label. Both are commonly grouped under "mitochondrial peptides" in supplier and literature shorthand, but they represent two distinct mechanistic categories within that broader label, not variations on the same mechanism.
Researchers designing a study around mitochondrial biology should treat "mitochondrial peptide" as a category label rather than a single mechanism, and select MOTS-C, SS-31, or another compound in the class based on which mechanistic category, signaling versus membrane structure, actually matches the research question. Background on the broader class is covered separately in our overview of MOTS-C and SS-31 (elamipretide) product documentation.
Purity, Identity, and Documentation Considerations
Because MOTS-C and SS-31 differ structurally, and because both are used in mechanistic research where compound identity matters to interpreting results, researchers evaluating either compound should look at the same set of documentation regardless of which peptide is under consideration:
- A certificate of analysis (COA) showing identity confirmation, typically by mass spectrometry, and a purity value, typically established by HPLC.
- A lot number on the vial that corresponds to the lot referenced on the COA, so the documentation can be tied to the specific unit received.
- Third-party testing status, distinct from in-house testing, since independent verification addresses a different source of error than internal quality control alone.
Coverage of certificates of analysis varies by product and by supplier catalog; not every listing has a published COA, and researchers should confirm documentation for the specific product and lot they intend to use rather than assuming coverage across an entire catalog. GPUSA publishes COAs on the product pages that have them, including current documentation for MOTS-C and SS-31 where available.
Practical Sourcing Considerations
Both compounds are typically supplied as lyophilized powder, which is stable at room temperature during shipping and storage. This matters for laboratories placing orders across the United States, since a room-temperature-stable format removes a logistical variable that a temperature-sensitive liquid format would introduce. For researchers who intend to examine MOTS-C and SS-31 in the same study design, for instance to compare a signaling-pathway peptide against a membrane-targeted peptide within the same mitochondrial research question, single-compound vials of each are generally preferable to a pre-mixed blend, since single-compound vials keep each peptide independently traceable to its own COA and lot number. A separate comparison of NAD+, another compound frequently discussed alongside mitochondrial research topics, is available for researchers building out a broader panel of cellular energy metabolism research compounds. The full catalog of research peptides is available in our collection of research compounds.
Choosing Between MOTS-C and SS-31 for a Study Design
The choice between these two compounds should follow directly from the research question rather than from their shared "mitochondrial peptide" label. A study designed around nuclear signaling, gene expression changes under metabolic stress, or AMPK-linked pathways sits within the research literature associated with MOTS-C. A study designed around membrane potential, cardiolipin interaction, or electron transport chain organization sits within the research literature associated with SS-31. Some research programs examining mitochondrial biology broadly may have use for both compounds as distinct tools addressing distinct mechanistic layers, rather than as substitutes for one another.
As with any compound comparison, researchers should base compound selection on the specific mechanistic pathway under investigation and verify current purity and identity documentation for the exact lot being used, rather than relying on general class-level assumptions.
Summary
MOTS-C and SS-31 are frequently mentioned together because both fall under the informal category of mitochondrial peptides, but they differ in origin (genome-encoded versus synthetic), primary site of interest (nuclear and cytoplasmic signaling versus inner membrane structure), and the type of research literature that has examined them. Selecting between them, or using both, should be driven by the specific mechanistic question a study is designed to address, supported by verified purity and identity documentation for the compound and lot in use.
For laboratory research use only. Not for human consumption.